The Food and Drug Administration has upgraded a December recall of Classic Lays Potato Chips to Class 1, the highest priority designated by the agency.
Federal regulators have warned a Waco, Texas, company that its human amniotic products are “unlicensed” and “unapproved,” and that its manufacturing process violates safety regulations. The U.S. Food & Drug Administration sent a warning letter to Frontier Biologics in November,
The recall affects 12-ounce bags of the product, which were sold in 20 states and pose serious health risks if consumed.
On Jan. 27 the FDA raised the risk classification to Class 1, the agency's highest risk classification for recalls
Houston-area candy manufactures react to the U.S. Food and Drug Administration's ban on red dye linked to cancer.
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
The FDA first announced on December 18, 2024, that Frito-Lay issued a recall on a “limited number” of the 13 oz bags of chips. These Lay’s Classic Potato Chips bags were recalled because they “may contain undeclared milk ,” which Frito-Lay learned “after being alerted through a consumer contact.”
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of the abortion pill mifepristone in the United States, a federal judge in Texas ruled on Thursday.
On Monday, a federal judge from the Eastern District of Texas, Judge J. Campbell Barker, ruled that the U.S. Food and Drug Administration
Trump-appointed Judge Matthew Kacsmaryk ruled Thursday that Idaho, Kansas, and Missouri can pursue legal action to prohibit the FDA from allowing online prescriptions.
The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market e-cigarettes in the conservative U.
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human